Michael W. Wathen

2.2k citations

44 papers · 1.9k indexed · h-index 26

Co-authors: Mark F. Stinski Roger J. Brideau D R Thomsen Nancee L. Oien Fred L. Homa Mary L. Knechtel Todd A. Hopkins Patti R. Shaver
Topics: Herpesvirus Infections and Treatments (20 papers)Respiratory viral infections research (17 papers)Cytomegalovirus and herpesvirus research (16 papers)
Cited by: Epidemiology Virology Parasitology
Journals: Biochemistry Journal of Virology Journal of Medicinal Chemistry
Partner nations: United States Canada Brazil

In The Last Decade

Michael W. Wathen

44 papers receiving 1.7k citations

Peers

Countries citing papers authored by Michael W. Wathen

Since Specialization

Citations

This map shows the geographic impact of Michael W. Wathen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael W. Wathen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael W. Wathen more than expected).

Fields of papers citing papers by Michael W. Wathen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael W. Wathen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael W. Wathen. The network helps show where Michael W. Wathen may publish in the future.

Co-authorship network of co-authors of Michael W. Wathen

This figure shows the co-authorship network connecting the top 25 collaborators of Michael W. Wathen. A scholar is included among the top collaborators of Michael W. Wathen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael W. Wathen. Michael W. Wathen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Antivirals in seasonal and pandemic influenza—future perspectives^* 2012 ·Influenza and Other Respiratory Viruses ·Michael W. Wathen,Mario Barro,Rick A. Bright	26
2	Modifications of C-2 on the pyrroloquinoline template aimed at the development of potent herpesvirus antivirals with improved aqueous solubility 2010 ·Bioorganic & Medicinal Chemistry Letters ·James A. Nieman,Sajiv K. Nair,(unknown),(unknown),(unknown),Richard A. Nugent,Ke Chen,(unknown),Todd A. Hopkins,Mary L. Knechtel,Nancee L. Oien,(unknown),Michael W. Wathen	30
3	The design and development of 2-aryl-2-hydroxy ethylamine substituted 1H,7H-pyrido[1,2,3-de]quinoxaline-6-carboxamides as inhibitors of human cytomegalovirus polymerase 2010 ·Bioorganic & Medicinal Chemistry Letters ·Steven P. Tanis,Joseph W. Strohbach,(unknown),(unknown),Suvit Thaisrivongs,(unknown),Todd A. Hopkins,Mary L. Knechtel,Nancee L. Oien,(unknown),(unknown),Michael W. Wathen	15
4	Synthesis of 4-oxo-4,7-dihydrofuro[2,3-b]pyridine-5-carboxamides with broad-spectrum human herpesvirus polymerase inhibition 2008 ·Bioorganic & Medicinal Chemistry Letters ·Mark E. Schnute,Roger J. Brideau,Sarah A. Collier,(unknown),Todd A. Hopkins,Mary L. Knechtel,Nancee L. Oien,(unknown),(unknown),(unknown),Michael W. Wathen,(unknown)	18
5	2-Aryl-2-hydroxyethylamine substituted 4-oxo-4,7-dihydrothieno[2,3-b]pyridines as broad-spectrum inhibitors of human herpesvirus polymerases 2007 ·Bioorganic & Medicinal Chemistry Letters ·Mark E. Schnute,David Anderson,Roger J. Brideau,Fred L. Ciske,Sarah A. Collier,(unknown),MariJean Eggen,Michaël Génin,Todd A. Hopkins,Thomas M. Judge,(unknown),Mary L. Knechtel,Sajiv K. Nair,James A. Nieman,Nancee L. Oien,(unknown),Steven P. Tanis,Valerie Vaillancourt,Michael W. Wathen,(unknown)	36
6	7-Oxo-4,7-dihydrothieno[3,2-b]pyridine-6-carboxamides: Synthesis and biological activity of a new class of highly potent inhibitors of human cytomegalovirus DNA polymerase 2007 ·Bioorganic & Medicinal Chemistry Letters ·Scott D. Larsen,Zhi‐Jun Zhang,(unknown),Peter R. Manninen,Douglas C. Rohrer,Michael J. Hageman,Todd A. Hopkins,Mary L. Knechtel,Nancee L. Oien,Bob D. Rush,Francis J. Schwende,Kevin Stefanski,(unknown),Karen F. Wilkinson,(unknown),Michael W. Wathen,Roger J. Brideau	8
7	Naphthalene carboxamides as inhibitors of human cytomegalovirus DNA polymerase 2000 ·Bioorganic & Medicinal Chemistry Letters ·Valerie Vaillancourt,(unknown),(unknown),Roger J. Brideau,(unknown),Mary L. Knechtel,Nancee L. Oien,(unknown),Yoshihiko Yagi,Michael W. Wathen	23
8	Functional analysis of human cytomegalovirus polymerase accessory protein 1994 ·Virus Research ·(unknown),Nancee L. Oien,Fred L. Homa,Michael W. Wathen	83
9	Induction of local and systemic immunity against human respiratory syncytial virus using a chimeric FG glycoprotein and cholera toxin B subunit 1994 ·Vaccine ·Nancee L. Oien,Roger J. Brideau,Edward E. Walsh,Michael W. Wathen	46
10	Purification of a Recombinant Human Respiratory Syncytial Virus Chimeric Glycoprotein Using Reversed-Phase Chromatography and Protein Refolding in Guanidine Hydrochloride 1994 ·Protein Expression and Purification ·Peter A. Wells,Robert Garlick,(unknown),(unknown),Roger A. Poorman,Roger J. Brideau,Michael W. Wathen	1
11	Development of a novel subunit vaccine that protects cotton rats against both human respiratory syncytial virus and human parainfluenza virus type 3 1993 ·Journal of General Virology ·Fred L. Homa,Roger J. Brideau,(unknown),D R Thomsen,Robert A. Olmsted,Michael W. Wathen	20
12	Vaccination with a heterologous respiratory syncytial virus chimeric FG glycoprotein demonstrates significant subgroup cross-reactivity 1993 ·Vaccine ·Nancee L. Oien,Roger J. Brideau,D R Thomsen,Fred L. Homa,Michael W. Wathen	8
13	A Human Respiratory Syncytial Virus (RSV) Primate Model of Enhanced Pulmonary Pathology Induced with a Formalin-Inactivated RSV Vaccine but Not a Recombinant FG Subunit Vaccine 1993 ·The Journal of Infectious Diseases ·Thomas J. Kakuk,Kenneth F. Soike,Roger J. Brideau,Renee M. Zaya,Suzanne Cole,Jinyong Zhang,E. D. Roberts,Peter A. Wells,Michael W. Wathen	80
14	A chimeric glycoprotein of human respiratory syncytial virus termed FG induces T-cell mediated immunity in mice 1991 ·Vaccine ·Roger J. Brideau,Michael W. Wathen	13
15	Characterization of oligosaccharide structures on a chimeric respiratory syncytial virus protein expressed in insect cell line Sf9 1991 ·Biochemistry ·Michael W. Wathen,Paul A. Aeed,Åke P. Elhammer	37
16	Vaccination of Cotton Rats with a Chimeric FG Glycoprotein of Human Respiratory Syncytial Virus Induces Minimal Pulmonary Pathology on Challenge 1991 ·The Journal of Infectious Diseases ·Michael W. Wathen,Thomas J. Kakuk,Roger J. Brideau,(unknown),Suzanne Cole,Renee M. Zaya	42
17	Production, Characterization, and Utility of Monoclonal Antibodies Which React with a Novel Chimeric Glycoprotein of Human Respiratory Syncytial Virus Termed FG 1989 ·Hybridoma ·Roger J. Brideau,Rodney R. Walters,Michael W. Wathen	2
18	Characterization of a Novel Human Respiratory Syncytial Virus Chimeric FG Glycoprotein Expressed Using a Baculovirus Vector 1989 ·Journal of General Virology ·Michael W. Wathen,Roger J. Brideau,D R Thomsen,Brian R. Murphy	43
19	Immunization of Cotton Rats with the Human Respiratory Syncytial Virus F Glycoprotein Produced Using a Baculovirus Vector 1989 ·The Journal of Infectious Diseases ·Michael W. Wathen,Roger J. Brideau,D R Thomsen	51
20	Characterization and mapping of a nonessential pseudorabies virus glycoprotein 1986 ·Journal of Virology ·Michael W. Wathen,(unknown)	33

About Michael W. Wathen

Michael W. Wathen is a scholar working on Epidemiology, Virology and Infectious Diseases, having authored 44 papers that have together received 1.9k indexed citations. Recurring topics across this work include Herpesvirus Infections and Treatments (20 papers), Respiratory viral infections research (17 papers) and Cytomegalovirus and herpesvirus research (16 papers). The work is most often cited by research in Epidemiology (1.6k citations), Virology (145 citations) and Parasitology (178 citations). Michael W. Wathen has collaborated with scholars based in United States, Canada and Brazil. Frequent co-authors include Mark F. Stinski, Roger J. Brideau, D R Thomsen, Nancee L. Oien, Fred L. Homa, Mary L. Knechtel, Todd A. Hopkins, Patti R. Shaver, Leslie Tengelsen and Nels E. Pederson. Their work appears in journals such as Biochemistry, Journal of Virology and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact